In non-small cell lung cancer (NSCLC), METTL3 enhances the stability of the lncRNA DLGAP1 antisense RNA 2 (DLGAP1-AS2), which interacts with YTHDF1 and promotes c-MYC mRNA stability via m6A modification [29]. Here, METTL3 is linked to non-small cell lung carcinoma.